循环RNA:一种新兴的精确武器,用于糖尿病病诊断和治疗
Haiying Shu1, Zhen Zhang2, Jieting Liu3
1Heilongjiang Key Laboratory of Anti-Fibrosis Biotherapy, Mudanjiang Medical University, Mudanjiang, China; College of Life Sciences, Mudanjiang Medical University, Mudanjiang, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|November 8, 2023
概括
循环RNAs (circRNAs) 是糖尿病病 (DN) 进展的关键调节者. 了解circRNA机制为DN诊断和治疗提供了新的途径.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 糖尿病病 (DN) 是慢性病和末期功能衰竭的主要原因.
- 目前的DN治疗只能提供症状缓解,无法阻止疾病的进展.
- 循环RNA (circRNAs) 是稳定的非编码RNA,在基因表达中起着调节作用.
研究的目的:
- 审查目前对DN中circRNAs的理解.
- 阐明circRNAs在糖尿病中影响细胞的机制.
- 突出circRNAs作为潜在的生物标记物和DNA的治疗点.
主要方法:
- 关于circRNAs和DN的最近研究的文献综述.
- 对circRNA分类,功能和监测方法的分析.
- 专注于circRNA对细胞损伤通路的影响.
主要成果:
- 循环RNA失调与DN进展密切相关.
- 循环RNAs调节细胞周期,分化和死亡.
- 循环RNAs影响DN中的炎症因子释放和纤维菌素表达.
结论:
- 循环RNA在DN病变发生过程中起着重要作用.
- 循环RNAs代表了DN的有希望的预测生物标志物.
- 向circRNAs为DN预防和治疗提供了潜在的治疗策略.
相关概念视频
Chronic Kidney Disease I: Introduction
17
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
Chronic Kidney Disease III: Interprofessional Care
13
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
Nephrotic Syndrome III : Nursing Management
17
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
17
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Renal Corpuscle
2.4K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


